Apnea clinical trials
The registry lists 282 studies for Apnea across more than 10 countries. 54 are recruiting or about to start. 140 of them are mainly about Apnea (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 4 narrower conditions too, such as Sleep Apnea, Obstructive: 3,232 studies, 613 open.
Get an email when these change. Save the Apnea studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Centro Universitario La Salle (7) · McGill University Health Centre/Research Institute of the McGill University Health Centre (5) · University of Alabama at Birmingham (5) · University of Manitoba (4) · Washington University School of Medicine (4) · University of Alberta (4) · Sunnybrook Health Sciences Centre (4) · University of Zurich (4)
What is being tested here
Drugs under test in Apnea studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Caffeine | 4 | 6 | 19 |
| Caffeine citrate | 4 | 6 | 17 |
| Berobenatide | 2 | 2 | 2 |
| Lemborexant | 1 | 0 | 2 |
| Doxapram | 1 | 1 | 2 |
| Rocuronium | 1 | 0 | 1 |
| Acetazolamide | 0 | 0 | 3 |
| Oxygen | 0 | 0 | 2 |
| Empagliflozin | 0 | 0 | 1 |
| 13-valent pneumococcal vaccine | 0 | 0 | 1 |
Drug classes tested here Stimulants 5 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest
- Dec 2026Caffeine Use in the Management of Preterm Infants · University of California, Irvine
- Dec 2026Home Ventilatory Support in Children · Tampere University Hospital
- Dec 2026Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety · Michael Harrison
- Dec 2026Wearable Technologies for Sleep in Children and Adolescents · SleepUp Tecnologia em Saúde Ltda
- Dec 2026Post-Extubation Assessment of Clinical Stability in ELBW Infants · McGill University Health Centre/Research Institute of the McGill University Health Centre
- Dec 2026Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates · Hospital San Carlos, Madrid
- Dec 2026Down Syndrome, Physical Activity and Sleep Apnea · University Hospital, Grenoble
- Jan 2027The Role of Electroencephalography in Caffeine Discontinuation Timing in Premature Infants · Uludag University
- Jan 2027Wireless MicroPremVitals Button Sensor in the NICU · McGill University Health Centre/Research Institute of the McGill University Health Centre
- Feb 2027Temporal Dynamics of Peripheral SpO₂ During Reoxygenation · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Who these studies take
Of the 40 Apnea studies recruiting now, 9 (23%) set no upper age limit and 27 (68%) stop at 75 or younger. 19 (48%) take children under 18. 2 (5%) are for women only and 0 (0%) for men only; 16 (40%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 9 (23%) | 9 (23%) |
| 18 | 22 (55%) | 21 (53%) |
| 30 | 22 (55%) | 20 (50%) |
| 40 | 22 (55%) | 20 (50%) |
| 50 | 21 (53%) | 20 (50%) |
| 65 | 22 (55%) | 21 (53%) |
| 75 | 14 (35%) | 13 (33%) |
| 85 | 12 (30%) | 11 (28%) |
Across all 282 studies, recruiting or not: 57% stop at 75 or younger and 51% at 65; 48% take children; 1% are for women only and 2% for men only; 29% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Apnea studies take
Of 78 interventional studies with no phase under Apnea, half reached primary completion within 17 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 17 mo8–35 · 78 studies | — | 19 mo10–37 · 69 studies |
| Observational | 23 mo14–38 · 35 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting1
Newly registered5
- nCPAP-NAVA-Backup Versus Standard nCPAP for Severe Apnea in Preterm Infants ≤28 WeeksNov 6, 2026NCT07923604
- HFNC vs Conventional Oxygen During Gastrocolonoscopy in Elderly PatientsNov 4, 2026NCT07916298
- Strap To Reduce Apnea in Preterm Infants: A Randomized Crossover TrialOct 26, 2026NCT07895654
- Temporal Dynamics of Peripheral SpO₂ During ReoxygenationOct 20, 2026NCT07884500
- A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)Oct 19, 2026NCT07881757
Studies
Recruiting first, then most recently updated. Showing 50 of 282. Browse all 282 → or search them.
- nCPAP-NAVA-Backup Versus Standard nCPAP for Severe Apnea in Preterm Infants ≤28 WeeksNot yet recruitingNCT07923604Not applicable1 country
- Clinical Assessment of the BreathAlert Device in Monitoring Apneic EpisodesRecruitingNCT077043201 country
- A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)RecruitingNCT07881757Phase 31 country
- A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)RecruitingNCT07823608Phase 31 country
- HFNC vs Conventional Oxygen During Gastrocolonoscopy in Elderly PatientsNot yet recruitingNCT07916298Not applicable1 country
- Strap To Reduce Apnea in Preterm Infants: A Randomized Crossover TrialNot yet recruitingNCT07895654Not applicable1 country
- Temporal Dynamics of Peripheral SpO₂ During ReoxygenationRecruitingNCT07884500Not applicable1 country
- Development and Investigation of the ApneaTheraPlayRecruitingNCT07214636Not applicable1 country
- Application to Predict Neonatal Apnea With BradycardiaRecruitingNCT06852053Not applicable1 country
- Does the Timing of Insomnia Therapy (CBT-i) Impact the Usage and Compliance of Upper Airway Stimulation (UAS) Treatment of Obstructive Sleep Apnea (OSA)Not yet recruitingNCT07838870Not applicable1 country
- Early Dental Risk Screening for Pediatric Sleep-Disordered BreathingRecruitingNCT075819381 country
- Clinical Evaluation of an Alarm Activated Detection System to Enable Early Intervention of Emerging Respiratory Decline With the Linshom Medical Continuous Predictive Respiratory Sensor (CPRS)Not yet recruitingNCT07793981Not applicable1 country
- Automated Apnoea Detection in Preterms on Non-invasive VentilationNot yet recruitingNCT07794007
- MICropsampling for CAffeine in PREMature NewbornsNot yet recruitingNCT07779915Not applicable1 country
- Detection of Respiratory Events Using Acoustic Monitoring in Extremely Preterm InfantsRecruitingNCT075520251 country
- Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in HypotoniaRecruitingNCT05527652Not applicable1 country
- Development of a Torso Patch Sensor (C-TraQ) as a Companion Device to a Fingertip Sensor (TipTraQ) for Direct Monitoring of Respiratory EffortRecruitingNCT077448541 country
- Caffeine Optimization for Oxygen Saturation Index in ELBW InfantsRecruitingNCT07216365Phase 21 country
- Wireless MicroPremVitals Button Sensor in the NICURecruitingNCT07732257Not applicable1 country
- The Optimal One-Month Dosing of Lemborexant for Moderate Obstructive Sleep Apnea (OSA) Patients With Low Arousal ThresholdNot yet recruitingNCT07683442Phase 1/21 country
- Fentanyl and Rocuronium for Tracheal Intubation in NewbornsNot yet recruitingNCT07650552Phase 41 country
- Caffeine Citrate in Preterm Infants at Risk of Apnea in ZambiaRecruitingNCT06518603Phase 41 country
- Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)RecruitingNCT04179981Not applicable1 country
- Pharmacokinetics and Placental Transfer of CaffeineRecruitingNCT07570121Phase 11 country
- Pediatric Obstructive Sleep Apnea Among Dental Interns in Egyptian UniversitiesNot yet recruitingNCT07604831
- The Role of Electroencephalography in Caffeine Discontinuation Timing in Premature InfantsRecruitingNCT073249411 country
- The PARS Study: Paediatric Advanced Respiratory Service Study - An Observational Diagnostic Feasibility StudyRecruitingNCT062922991 country
- Supplemental Oxygen and Oxygen Desaturations in ColonoscopiesNot yet recruitingNCT07515755Not applicable1 country
- Post-Extubation Assessment of Clinical Stability in ELBW InfantsRecruitingNCT060370831 country
- Upper Airway's Pressure Drop Analyses After Mandibular Advancement and Maxillary ExpansionRecruitingNCT04190953Not applicable1 country
- Efficacy of PIMUN by Reducing Intermittent Hypoxia EventsRecruitingNCT07396103Not applicable1 country
- Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and SafetyRecruitingNCT02431507Not applicable1 country
- The Effectiveness of Oxygen Reserve Index in Early Detection of Desaturation in Geriatric Patients Scheduled for Oncological SurgeryRecruitingNCT073262931 country
- The Effect of Caffeine Therapy in Cardiovascular Stability in Preterm Neonates at Assiut University Children Hospital NICUNot yet recruitingNCT07274969
- The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm InfantsRecruitingNCT05298748Not applicable1 country
- Wearable Technologies for Sleep in Children and AdolescentsRecruitingNCT062378421 country
- Effort-based Decision-making and CPAP AdherenceRecruitingNCT04557293Not applicable1 country
- Value of Screening and Treatment of SAHS in the Management of AF Ablation CandidatesRecruitingNCT04606693Not applicable1 country
- Hypoglossal Nerve Stimulation Therapy in Patients With Obstructive Sleep Apnea: Belgian RegistryRecruitingNCT063324041 country
- Non-inferiority Analysis of Two Titration Methods for Hypoglossal Nerve Stimulation TherapyRecruitingNCT065599561 country
- The Role of Oxygen Reserve Index (ORi) in Apneic VentilationNot yet recruitingNCT071198661 country
- Caffeine Citrate to Improve Neonatal Outcomes.Not yet recruitingNCT06972849Not applicable
- "Prapela® SVS Incubator Pad for Apnea of PrematurityRecruitingNCT06374147Not applicable1 country
- Effects of Walking Apnea At High Lung Volume on HypoalgesiaRecruitingNCT06638528Not applicable1 country
- Effects of Walking Apnea At Low Lung Volume on HypoalgesiaRecruitingNCT06638515Not applicable1 country
- The Effect of an Additional Pre-extubational Loading Dose of Caffeine-citrateRecruitingNCT06401083Phase 41 country
- Doxapram Therapy in Preterm Infants (DOXA Trial)RecruitingNCT04430790Phase 33 countries
- Effect of Diaphragmatic Release in Sleep Quality During PregnancyRecruitingNCT06273787Not applicable1 country
- Down Syndrome, Physical Activity and Sleep ApneaRecruitingNCT060615621 country
- Effects of Static Apnea at High Lung Volume on Hypoalgesia, Cardiovascular Function and Respiratory FunctionRecruitingNCT06150677Phase 31 country